LISA LONG: Open Payments
NPI 1356831572 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 82 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,438 · 2025 $1,345
Food & beverage: $1,327Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $307 |
| Janssen Biotech, Inc. | 6 | $153 |
| Novartis Pharmaceuticals Corporation | 6 | $153 |
| GENZYME CORPORATION | 10 | $152 |
| Incyte Corporation | 18 | $135 |
| Lilly USA, LLC | 5 | $103 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $74 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $71 |
| LEO Pharma Inc. | 3 | $68 |
| Galderma Laboratories, L.P. | 3 | $48 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, OPZELURA, RINVOQ, Rhapsido, TALTZ, Cabtreo.
Industry payments across NM — which companies pay providers there.
